posted on 1996-02-09, 00:00authored byDavid Bonnaffé, Bernadette Dupraz, Joël Ughetto-Monfrin, Abdelkader Namane, Yvette Henin, Tam Huynh Dinh
Three general methods for the synthesis of acyl nucleotides
(mono-, di-, and triphosphates) have
been developed and applied to different HIV inhibitors. These new
types of compounds, where a
fatty acid moiety is linked to the nucleotide phosphate chain by an
acyl phosphate bond, were
designed as lipophilic prodrugs of HIV inhibitors metabolites.
Acyl nucleoside monophosphates
1a,b were prepared by acylation of the corresponding
nucleoside monophosphates. Acyl nucleoside
diphosphates 2a−c and
3a,b were synthesized directly from the free nucleosides
using DCC
activation of acyl pyrophosphates. Acyl nucleoside triphosphates
4a−c and 5a were obtained
using
phosphoromorpholidate chemistry and acyl pyrophosphates as
nucleophiles. Hydrolysis of acyl
nucleotides liberated the corresponding nucleotides by selective
cleavage of the acyl phosphate bond,
with half lives ranging from 51 to 185 h at 37 °C in triethylammonium
acetate buffer pH 7.0.
Their antiretroviral activity, measured by the inhibition of
cytopathogenicity and reverse transcriptase activity in the cultures supernatants, did not reveal any
differences between an acyl
nucleotide and its corresponding nucleotide. These results are
explained in term of rapid aminolysis
of the acyl phosphate bond in culture media.